OGN vs SIBN · P/E 3.4, rev $3.02B vs rev $108.6M
Organon & Co (OGN) versus Si-Bone Inc (SIBN) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Si-Bone Inc (SIBN) is a medical devices company listed on NASDAQ.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported SIBN revenue for 2026-06-30 was $108.6M. Net income was -$8.4M. SIBN currently screens at market cap $674.6M.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. SIBN currently screens at market cap $674.6M.
Not investment advice. Open the OGN and SIBN stock pages for the full models.
Not investment advice.